Unknown NA INTERVENTIONAL 2-arm NCT00766480

Study of Tissue Samples in Predicting How Well Chemotherapy and Radiation Therapy Will Kill Cancer Cells in Patients With Squamous Cell Carcinoma of the Esophagus

An Investigational Study of Chemoradiosensitivity Prediction With Genetic Profiling of Esophageal Biopsy for Squamous Cell Carcinoma of the Esophagus

Sponsor: University of Toyama

Conditions Esophageal Cancer

Interventions cisplatin fluorouracil radiation therapy

Updated 6 times since 2017 Last updated: Aug 23, 2013 Started: Jan 31, 2007 Primary completion: Mar 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Esophageal Cancer, this trial is ongoing. The trial is conducted by University of Toyama and has accumulated 6 data snapshots since 2007. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Unknown NA
Sep 2024 — Sep 2025 [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Jun 2018 — Jan 2021 [monthly]

Unknown Status NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Unknown Status NA

First recorded

Jan 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Toyama

Data source: National Cancer Institute (NCI)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Fukuoka, Japan , Hiroshima, Japan , Kagoshima, Japan , Kashiwa, Japan , Kurashiki, Japan , Kurume, Japan , Kyoto, Japan , Maebashi, Japan , Morioka, Japan , Nagoya, Japan and 8 more locations